Neoadjuvant Trastuzumab and Paclitaxel Combination Induces a High Rate of Pathological Complete Responses in Locally Advanced Breast Cancer by Exploiting Host Antitumor Immunity.

Conference Proceedings

R Dolcetti, D Crivellari, E Muraro, D Martorelli, G Miolo, D Lombardi, S Massarut, T Perin, R Talamini, E Turchet, E Comaro, A Carbone, A Veronesi

CANCER RESEARCH | AMER ASSOC CANCER RESEARCH | Published : 2011